Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol prolonged-release for severe chronic knee osteoarthritis pain
2009-010423-58Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of tapentadol in osteoarthritis (OA) and knee osteoarthritis (OA), sponsored by Grünenthal GmbH. Started May 2009; status: completed.
02
Drugs
tapentadol
03
Conditions
osteoarthritis (OA)knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2009-010423-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010423-58.